Pluri Inc. (NasdaqCM: $PLUR, TASE: PLUR) is a clinical-stage biotech company creating next-generation cell-based products that advance solutions to humanityโs g
June 14 is #WorldBloodDonorDay - a reminder that access to safe blood saves lives. On this important day, we thank the millions of donors worldwide and our partners in development of next generation medicine promoting bone marrow regeneration.
#BloodDonation#CellTherapy#Pluri
Thank you, @i24NEWS for sharing our innovative #foodtech initiatives - cultivated Cacao and Coffee. Pluri's technologies, with Kokomodo's and Coffeesai's developments, enable scalable, sustainable solutions for a growing world.
8B people. 1 planet. 0 time to waste.
We need scalable solutions with a smaller footprint.
At Pluri, weโre advancing cell-based solutions designed for a lower ecological footprint.
Sustainability isnโt optional. Itโs the future of how we produce. ๐
#WorldEnvironmentDay
From lab to market: Pluriโs subsidiary Cellav, completes U.S. listing of 2 regenerative aesthetic products, opening the door to commercial launch in the U.S. and entry into a fast-growing aesthetics market.
Next generation of food wonโt be defined by a single product, but by the production platform that can scale. Powered by #Pluri's cell expansion technology, Ever After Foods produces mass scale, cost-effective food products in an efficient and sustainable manner. #Cultivatedfood
youtu.be/2RK8OLxucWI
How can biotechnology help solve some of the worldโs biggest health and food challenges?
I recently sat down with Yaky Yanay, CEO and President of @Pluribiotech (NASDAQCM, TASE: PLUR), to discuss how the company is scaling cell production in ways that could transform medicine, agriculture, and food systems.
Pluri has developed a patented 3D cell expansion platform that enables large scale, cost efficient manufacturing of human, animal, and plant cells.
Yanay describes it as a unified biotech platform with applications ranging from regenerative medicine and wound healing to cultivated coffee, cocoa, meat, and seafood.
As global healthcare needs and food supply pressures grow, Pluri is focused on delivering science backed solutions using one powerful cell production system. #Biotechnology
Get ready for the Miss Universe competition!๐โจWeโre proud to join MissUniverse Skincare in unveiling its new partnership with Cellav by Pluri, bringing cell-based skincare innovation to the global stage. ๐#MissUniverse#RegenerativeBeauty@YakyYanay
Science meets beauty. โจMeet Cellav Health and Aesthetics Ltd., powered by Pluriโs cell-based innovation to bring regenerative science to skincare. ๐ซLearn more: https ://pluri-biotech.com/revolutionizing-the-beauty-industry/ #BiotechBeauty#Innovation
Honored to be named Overall BioAgriculture Company of the Year by the Biotech Breakthrough Awards! ๐ฑ๐
Our ventures are also driving impact โ from cell-based coffee (Coffeesai) and cacao (Kokomodo) to regenerative biotech
๐ pluri-biotech.com/releases/pโฆ#CellTherapy#Sustainability
Big news! ๐
Pluri launches Cellav, our new health & aesthetics subsidiary and weโre partnering with Miss Universe Skincare to co-develop a revolutionary exosome-enhanced, cell-based skincare line launching in 2026: pluri-biotech.com/releases/pโฆ#MissUniverseSkincare#Exosomes
๐ Leading global players join forces with Pluriโs subsidiaries to transform food & agriculture.
Each collaboration is funded by global partners to co-develop MVPs for a sustainable, cell-based future. ๐ฑ
Read more: pluri-biotech.com/releases/lโฆ#FoodTech#AgTech